Comment
5
6 7 8
9 10
Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992; 326: 1102–07. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326: 1097–101. Hewitt M, Simone JV. Ensuring quality cancer care. Washington DC: National Academy Press and Institute of Medicine National Research Council, 1999. Caldon LJM, Walters SJ, Reed JA, Murphy A, Worley A, Reed MWR. Case-mix fails to explain variation in mastectomy rates: management of screendetected breast cancer in a UK region 1997–2003. Br J Cancer 2005; 92: 55–59. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care. Cancer 1999; 86: 2378–90. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996; 88: 716–26.
11
12
13
14
15 16
Mandelblatt JS, Berg CD, Meropol NJ, et al. Measuring and predicting surgeons’ practice styles for breast cancer treatment in older women. Med Care 2001; 39: 228–42. Liang W, Burnett CB, Rowland JH, et al. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 2002; 20: 1008–16. Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E. Consultation with a medical oncologist before surgery and type of surgery among elderly women with early stage breast cancer. J Clin Oncol 2003; 21: 4532–39. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999; 49: 651–61. Lipscomb J, Donaldson MS, Arora NK, et al. Cancer outcomes research. J Natl Cancer Inst Monogr 2004; 33: 178–97. Lantz PM, Zemencuk JK, Katz SJ. Is mastectomy overused? A call for an expanded research agenda. Health Serv Res 2002; 37: 417–31.
The Wakley Prize 2005 “Nine o’clock at the obstetric high-risk clinic. A nurse waiting outside the door of the examination room gives me a warning look. ‘He’s dangerous, angry. He’s wearing brass knuckles as part of his attire.’ ‘He? What about she?’ ‘You’ll see”, said the nurse ominously.
So began the essay1 by Prof Nergesh Tejani that won our annual essay-writing competition last year—the Wakley Prize. We now invite submissions for this year’s Prize. Your essay can be on any clinical topic of international health importance. The winning author will receive £2000 and
the essay will be published in the final issue of the year. Anyone working or training in a health-related field may apply. Your essay should be no more than 2000 words, and the deadline is Sept 30, 2005. The essays will be judged (without knowing the authors’ identities) by the editors of The Lancet. Style, subject, poignancy, readability, and international relevance are the criteria Lancet editors use to select the winners.2 Since the Prize began in 1996, we have chosen one winner every year, except for 2003, when we were unable to choose between Amanda Kvalsvig’s powerful description of her deafness3 and Jaime Miranda’s evocative reflections on the lives of people with tuberculosis4—we published both. These, and all previous winning essays,5–11 were, and remain, a pleasure to read. To enter, please send three anonymised double-spaced copies of your essay, together with a covering letter, to The Editor, The Lancet, 32 Jamestown Road, London NW1 7BY, UK, in an envelope marked “Wakley Prize”. Astrid James The Lancet, London NW1 7BY, UK 1 2 3 4 5
David Shand
6 7 8
Bust of Thomas Wakley Wakley founded The Lancet in 1823. His bust is now in The Lancet’s library, with volumes of the bound journal from 1823 to the present day.
190
9 10 11
Tejani N. Maria. Lancet 2004; 364: 2223. James A. The Wakley Prize 2003 winners. Lancet 2003; 362: 2038. Kvalsvig A. Ask the elephant. Lancet 2003; 362: 2079–80. Miranda JJ. TB and you and me . . . personal reflections. Lancet 2003: 362: 2081–82. Loefler IJP. Microbes, chemotherapy, evolution, and folly. Lancet 1996; 348: 1703–04. Karlawish J. A personal choice. Lancet 1997; 350: 1833–34. Power L. Good times. Lancet 1998; 352: 1999–2000. Whitty CJM. Erasmus, syphilis, and the abuse of stigma. Lancet 1999; 354: 2147–48. Nauwelaers J. Eraritjaritjaka. Lancet 2000; 356: 2169–70. de Costa C. Flora’s legacy. Lancet 2001; 358: 2162–63. Parrish AG. Country gardens. Lancet 2002; 360: 2059–60.
www.thelancet.com Vol 366 July 16, 2005